BDSX (STOCKS)
Biodesix, Inc. Common Stock
$15.600000
+0.540000 (+3.59%)
Prev close: $15.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Scott Hutton
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $162.59M
- Employees
- 273
- P/E (TTM)
- -3.74
- P/B (TTM)
- 16.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.81 | $-1.12 | +0.3079 | +27.54% |
|
Dec 2025 (Q4)
|
$-0.49 | $-0.87 | +0.3821 | +43.81% |
|
Sep 2025 (Q3)
|
$-1.16 | $-1.47 | +0.3088 | +21.02% |
|
Jun 2025 (Q2)
|
$-1.60 | $-1.39 | -0.2061 | -14.79% |
Financial Statements
| Revenues | $96.10M |
| Benefits Costs and Expenses | $66.08M |
| Costs And Expenses | $124.64M |
| Nonoperating Income/Loss | -$7.02M |
| Operating Expenses | $121.03M |
| Selling, General, and Administrative Expenses | $91.36M |
| Depreciation and Amortization | $5.63M |
| Research and Development | $12.42M |
| Other Operating Expenses | $11.64M |
| Operating Income/Loss | -$24.94M |
| Income/Loss From Continuing Operations After Tax | -$31.96M |
| Income/Loss From Continuing Operations Before Tax | -$1.47M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $8.01M |
| Net Income/Loss | -$31.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$31.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$31.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $103.00K |
| Basic Earnings Per Share | -$2.48 |
| Diluted Earnings Per Share | -$2.48 |
| Basic Average Shares | 163,985,000 |
| Diluted Average Shares | 163,985,000 |
| Assets | $94.64M |
| Current Assets | $40.91M |
| Noncurrent Assets | $53.73M |
| Fixed Assets | $24.19M |
| Intangible Assets | $3.45M |
| Other Non-current Assets | $26.08M |
| Liabilities | $85.51M |
| Current Liabilities | $14.49M |
| Accounts Payable | $3.65M |
| Wages | $5.54M |
| Other Current Liabilities | $5.30M |
| Noncurrent Liabilities | $71.02M |
| Long-term Debt | $50.00M |
| Other Non-current Liabilities | $21.01M |
| Equity | $9.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.13M |
| Liabilities And Equity | $94.64M |
| Net Cash Flow From Operating Activities | -$24.84M |
| Net Cash Flow From Operating Activities, Continuing | -$24.84M |
| Net Cash Flow From Investing Activities | -$410.00K |
| Net Cash Flow From Investing Activities, Continuing | -$410.00K |
| Net Cash Flow From Financing Activities | $33.22M |
| Net Cash Flow From Financing Activities, Continuing | $33.22M |
| Net Cash Flow | $7.97M |
| Net Cash Flow, Continuing | $7.97M |
| Comprehensive Income/Loss | -$31.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$31.96M |
| Other Comprehensive Income/Loss | $0.00 |